Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$94.62 +1.44 (+1.55%)
As of: Nov 10, 2026 · 3:32 PM EST

Mirum Pharmaceuticals (MIRM) EV to EBITDA (2025)

Updated

Mirum Pharmaceuticals' EV to EBITDA came in at 965.94 for Q4 2025.

Analysis

Mirum Pharmaceuticals (MIRM) EV to EBITDA (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Mirum Pharmaceuticals 6.06 Bn 4.48 Bn 150.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 965.94
API Access

Mirum Pharmaceuticals EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=MIRM&period=max&api_key=YOUR_API_KEY